Akanda's U.S.-listed shares jump on cannabis supply pact

Tetra Bio Pharma

12/07/2022 14:21

** U.S.-listed shares of Akanda Corp  AKAN.O  jump 38% to
$1.08 premarket on pact to supply pharmaceutical grade cannabis
to Tetra Bio-Pharma  urn:newsml:reuters.com:*:nPnc93vTWa
    ** Under deal, UK-based medical cannabis company AKAN to be
contract development and manufacturing organization for Tetra's
clinical drug and commercial supply programs, in addition to
being an EU GMP cannabis manufacturer
    ** Deal marks AKAN's entry into cannabinoid drug development
    ** AKAN shares down 80% from its IPO price of $4, up to last
close; stock listed in March  urn:newsml:reuters.com:*:nASM0003IO

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))